Nutex Health (NUTX) Invested Capital (2010 - 2026)

Nutex Health (NUTX) has 17 years of Invested Capital data on file, last reported at $458.8 million in Q1 2026.

• Quarterly Invested Capital rose 76.48% year-over-year to $458.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $458.8 million (up 76.48% YoY) and the FY2025 annual result came in at $656.2 million, up 239.93% from the prior year.
• Invested Capital declined to $458.8 million in Q1 2026 per NUTX's latest filing, from $656.2 million in the prior quarter.
• The five-year high for Invested Capital was $656.2 million in Q4 2025, with the low at $82.7 million in Q4 2023.
• Average Invested Capital over 5 years is $244.1 million, with a median of $158.7 million recorded in 2022.
• Year-over-year, Invested Capital slumped 78.22% in 2023 and jumped 426.69% in 2025.
• Nutex Health's Invested Capital stood at $158.7 million in 2022, then tumbled by 47.87% to $82.7 million in 2023, then soared by 133.4% to $193.0 million in 2024, then soared by 239.93% to $656.2 million in 2025, then slumped by 30.08% to $458.8 million in 2026.
• Business Quant data shows NUTX's Invested Capital at $458.8 million in Q1 2026, $656.2 million in Q4 2025, and $442.8 million in Q3 2025.